NCS America changes its name as part of an overall rebranding initiative.
“As founder of NCS America, I am proud to share this important evolution: the creation of Alyve Medical. This name change reflects our positioning and the growth potential for our technologies. Together, we intend to disrupt and enhance the standard of musculoskeletal care” Matteo Mantovani, CEO of NCS Lab s.r.l. and co-founder of NCS America in response to the new name.
NCS America, Inc. was the initial U.S. organization created for the business operations and commercialization of the two products developed at NCS Lab srl in Carpi, Italy. Alyve Medical will continue to be the business entity for global operations and commercialization.
Alyve Medical, Inc. emphasizes the “y”, for you, focused on the individualized treatment that its products provide. It also serves as an ally to the patient or athlete to support them in their musculoskeletal health and optimization.
Alyve Medical Inc. is a novel medical technology company focused on reimagining the management of musculoskeletal care.
The two innovative and novel platforms (Shoulder Pacemaker™ and ShowMotion™) developed by NCS Lab Srl (Carpi, Italy) and released for sale to the EU, USA and many International Markets, will be the main focus of the new entity to aid worldwide clinicians in diagnosing, treating and preventing musculoskeletal injuries.
These non-invasive technologies, deployed in physician offices and physical therapy clinics today are being used to observe normal and abnormal joint function in orthopedic treatments, physical therapy delivery, and athletic performance.
Multiple studies are in progress validating and confirming this transformation in the way human movements are evaluated, measured and rehabilitated.
Alyve Medical, Inc. appoints new CEO: Yvonne Bokelman
After being NCS Company Chief Operating Officier through the past four months, Yvonne Bokelman has been appointed new CEO of Alyve Medical.
“I am honored by this opportunity,” said Ms. Bokelman. “The talent and passion of the team combined with the innovative products that they have developed create a unique go-to-market environment in which to excel. To lead a company that has novel, first-in-class products that can change the paradigm of care and positively impact patients’ lives and athletes’ training and recovery is incredibly energizing. This period in the company’s evolution presents an unparalleled opportunity for our current and future stakeholders as well as the team.”
Prior to joining NCS and Alyve Medical, Ms. Bokelman held the position of President and General Manager of Restorative Therapies, Market Access and Clinical Affairs at Zimmer Biomet. In her over ten years at Zimmer Biomet, she held a number of increasingly responsible leadership and executive roles.
With the overall company rebranding, the Shoulder Pacemaker™ name will change and both Shoulder Pacemaker™ and Showmotion™ will be transitioning to new graphics and logos.
To align with the company’s direction and to meet market demands, Shoulder Pacemaker™ and Showmotion™ will be transitioning their “look” in the coming weeks and months.
Join us in celebrating a new name for Shoulder Pacemaker™ as it becomes Neuralign System™ S.
A new brand, with the same product quality and customer care known to date, but with a new look to the future.
All customers who are now in possession of Shoulder Pacemaker™ and Showmotion™ will continue to be followed by our growing team, with the same care and attention to detail that distinguished NCS.
Our customer care department is available to support you for technical and commercial needs.
To learn more about Alyve Medical we invite you to visit the website www.alyvemedical.com and follow our social channels to stay updated on new developments.
Carpi 3000 sceglie Shoulder Pacemaker™ e Showmotion™: il primo starter KIT in Italia, per una riabilitazione all’avanguardia.
Carpi 3000, poliambulatorio specialistico di riferimento per la città di Carpi, ha deciso di implementare i propri servizi scegliendo la tecnologia di Shoulder Pacemaker™ e Showmotion™ di NCS Company.
Carpi 3000: il poliambulatorio specialistico di riferimento per la città di Carpi
Carpi 3000 è un poliambulatorio specialistico, punto di riferimento in città, che si rivolge a pazienti con disturbi di tipo ortopedico, neurologico, degenerativo e traumatico.
A Carpi 3000 ogni paziente è seguito da medici specializzati e da fisioterapisti qualificati per garantire la migliore cura e attenzione: dall’identificazione di una diagnosi, al recupero attraverso programmi clinici e riabilitativi specifici e con strumenti all’avanguardia.
La tecnologia di Showmotion™ e Shoulder Pacemaker™ per il benessere della spalla
Showmotion™ e Shoulder Pacemaker™ sono due device di NCS che, abbinando uno strumento di motion capture ad un dispositivo che introduce un nuovo concetto di stimolazione guidata dal movimento, contribuiscono al ripristino della corretta funzionalità di spalla.
Dott.ssa Tizia Ghelfi – Fisioterapista e Titolare del centro Carpi 3000
“Con Showmotion™ non solo abbiamo la possibilità di formulare diagnosi più accurate, ma soprattutto di monitorare il percorso del paziente in modo analitico, passo dopo passo.
Shoulder Pacemaker™ per noi è una vera innovazione nel panorama della riabilitazione di spalla, non poteva non essere presente in un centro come il nostro…” afferma Tiziana Ghelfi, titolare del centro.
Il primo starter kit in Italia
Carpi 3000 è il primo centro in Italia che ha scelto di avvalersi della formula Starter Kit “Avere a disposizione uno starter kit di questo tipo significa poter garantire al paziente le cure migliori, direttamente presso il centro, ma anche a casa grazie ai dispositivi specificatamente customizzati ad uso domestico, sempre supervisionati dal fisioterapista.” continua sempre Tiziana Ghelfi.
Lo starter kit comprende:
1 Showmotion™ Total Body con 12 sensori
2 KIT SHOULDER PACEMAKER™ wireless app
10 KIT SHOULDER PACEMAKER™ WIRELESS APP HOME
Lo starter kit rappresenta quindi un bundle completo per coloro che decidono di inserire la tecnologia di #SM e #SPM all’interno del proprio centro, offrendo al paziente un percorso completo che supporta la diagnosi, valuta e monitora gli avanzamenti e permette la continuità di riabilitazione anche a casa. (Per informazioni in merito alla configurazione dello STARTER KIT vi invitiamo a contattare il product specialist di riferimento, Matteo Barbolini: productspecialist1@ncs-company.com)
Showmotion™ & Shoulder Pacemaker™ protagonisti nel primo progetto di screening muscolo-scheletrico in Italia.
Si è tenuta qualche giorno fa a Peccioli (PI) l’assemblea pubblica di presentazione del progetto “Peccioli over 50 in salute”: il primo progetto di screening in Italia per patologie muscoloscheletriche rivolto a tutti i cittadini over 50 prese.
Il progetto Peccioli over 50 in salute
Il progetto, presentato dal Dr. Michele Novi (Dirigente medico della struttura organizzativa complessa di ortopedica protesica dell’ospedale di S. Pietro Igneo di Fucecchio), allievo del Prof. Michele Lisanti e del Prof. Giuseppe Porcellini, lo vedrà impegnato, insieme alla sua squadra, in un progetto di prevenzione finalizzato all’inclusività e intensità di cure anche verso i soggetti più fragili.
Un intervento molto importante perché ogni anno il numero di persone interessate da patologie muscolo-scheletriche legate alle articolazioni di spalla – ginocchio ed anca è in aumento, considerando inoltre che la pandemia ha evidenziato ulteriormente i limiti e le difficoltà del sistema tradizionale di riabilitazione a causa delle limitate possibilità di movimento e per i provider a causa delle nuove regole imposte dall’emergenza sanitaria.
Showmotion™ & Shoulder Pacemaker™ a servizio della prevenzione
Showmotion™ & Shoulder Pacemaker™ si inseriscono in questo progetto in maniera circolare attraverso le 3 fasi di: prevenzione, riabilitazione, monitoraggio.
L’assemblea pubblica è stata l’occasione per NCS di illustrare le principali funzionalità e caratteristiche dei dispositivi che saranno utilizzati in questo ambizioso progetto.
Showmotion™
Nella fase di screen sarà quindi utilizzato Showmotion come strumento di supporto alla diagnosi, utile per acquisire i dati cinematici.
Sowmotion™ è uno strumento innovativo che permette di eseguire un’analisi completa del movimento ottenendo contemporaneamente dati sull’attivazione muscolare.
Attraverso l’utilizzo di una piattaforma inerziale e di protocolli validati per gli arti superiori e inferiori, Showmotion™ permette di misurare, registrare, segmentare, confrontare, visualizzare i movimenti e fornire una rappresentazione visiva delle variabili coinvolte, portando alla luce eventuali disfunzionalità grazie ad un’analisi real-time del movimento.
>>> Per maggiorni informazioni sulla tecnologia fai clic QUI
Shoulder Pacemaker™
Altro protagonista del progetto di screening “Peccioli in Salute” è Shoulder Pacemaker™
Shoulder Pacemaker™ è un sistema che grazie al sensore cinematico presente al suo interno, riconosce il movimento e attiva l’elettrostimolazione solo quando necessario.È concepito per pazienti affetti da uno squilibrio nel reclutamento muscolare ed è dotato di una piattaforma che consente ai pazienti di interagire dinamicamente con il dispositivo durante la riabilitazione attiva.
>>> Per maggiori informazioni sulla tecnologia fai clic QUI
Un progetto pilota per il rinnovo della telemedicina in Italia
Il progetto Peccioli over 50 in “salute” si traduce nel tentativo di instaurare un sistema di trattamento virtuoso che permette di avvicinare i providers ai pazienti, monitorare l’intero processo fino al risultato finale e certificare l’esito ultimo.
Un progetto pilota che pone le basi per innovare il recente campo della telemedicina e divenire un unicum in Italia, in cui la popolazione eterogenea di un paese intero può accedere a tecnologie oggi ad appannaggio solo di sportivi professionisti o grandi centri universitari con finalità di studio.
È un onore per NCS vedere come, le tecnologie innovative di Shoulder Pacemaker™ e Showmotion™, possano contribuire in modo reale al miglioramento della salute dei pazienti, e della popolazione
NCS America, Inc. launches the Shoulder Pacemaker™ after receiving FDA clearance
NCS America, Inc. a world leader in developing technology to help diagnose, treat and prevent musculoskeletal injuries, today announced the expansion of their breakthrough product offerings with the FDA clearance of the Shoulder Pacemaker™ and its patented motion activated stimulation (MAS) technology.
What is the Shoulder Pacemaker™ device?
The Shoulder Pacemaker™ is an NMES device designed for use in muscle re-education, maintaining or increasing range of motion, and in the prevention or retardation of disuse atrophy.
Matteo Mantovani Technical Director – CEO, NCS Lab
“Motion activated stimulation is taking NMES to a new level“ said Matteo Mantovani, CEO and technical director of NCS Lab srl.
“This product advances NMES therapy with the ability to deliver stimulation with precision and accuracy in order to help re-educate imbalance muscular activity in the shoulder. Stimulation controlled by movement means restoring the right muscles recruitment pattern. In addition to this, automatic remote monitoring and reporting, checking both for the patient’s compliance and evolution, represent a significant benefit for patients and healthcare providers.
John Winslow CEO – NCS America, Inc.
John Winslow CEO – NCS America, Inc.John Winslow, CEO of NCS America, Inc. says “We are very pleased to receive the FDA clearance of the of the Shoulder Pacemaker™ which provides an exciting extension to the NCS product portfolio for the United States market. Our experience in Europe has proven that the market’s interest in motion activated muscle stimulation (MAS) is far beyond our original expectations. We are happy to make the device available in the U.S. to caregivers whose patients will benefit from this technology.”
NCS America, Inc.
NCS America, Inc. is the U.S. headquarter of NCS, a global medical device company focused on upper extremity and orthopedic pathologies.
With our deep understanding and experience in the biomechanics of the shoulder we design, manufacture and market technology that assists caregivers in the diagnosis, treatment and prevention of orthopedic injuries.
With operational headquarters in Carpi, Italy and in the U.S. in Denver, Colorado, NCS’s products are sold in over 20 countries via the Company’s sales representatives and distributors.
John Winslow CEO – NCS America, Inc.
j.winslow@ncs-company.com
970-980-1110
Craig Kramer VP of Business Development – NCS America, Inc.
c.kramer@ncs-company.com
317-441-4289
Forward-Looking Statements
This communication contains forward-looking statements. Any or all forward-looking statements that we make may turn out to be wrong (due to inaccurate assumptions that we make or otherwise), and our actual outcomes and results may differ materially from those expressed in these forward-looking statements. You should not place undue reliance on any of these forward-looking statements. Further, any forward-looking statement speaks only as of the date hereof, unless it is specifically otherwise stated to be made as of a different date. We undertake no obligation to update, and expressly disclaim any duty to update, our forward-looking statements, whether as a result of circumstances or events that arise after the date hereof, new information, or otherwise.
Why is transosseous arthroscopy considered the gold standard in rotator cuff repair?
The transosseous approach is generally recognized as the gold standard for surgical repair of the rotator cuff.
We can list here the main reasons:
Widely recognized by the scientific community
Numerous supporting publications
No hardware in the footprint
Possibility to decorticate
Larger tendon-bone contact area
Uniform force distribution - no load peaks
Biologically better repair
Transosseous Arthroscopy: advantages
What are the advantages for the patient? And for the physician?
With the transosseous approach, you have the ability to manage any type of rotator cuff injury.
Combined with a proper rehabilitation protocol, patients have a faster functional recovery and the rehabilitation phase has less pain than other comparable procedures.
On the other hand, for the physician, transosseous repair means:
Biologically better repair
Optimal management of revision cases, cysts and osteoporotic bone (with augmentation)
Cost-effective
Transosseous Arthroscopy: critical issues
But What are the main errors and critical issues that can be encountered?
As with other techniques, critical issues or steps that require a major learning curve may be encountered in TO.
We have identified the following:
How to load sutures in a Transosseous Tunnel
How to create multiple tunnels?
Converging tunnels, how to do it?
How to access the lateral part of the greater tuberosity: what are the difficulties when going distal, and can the axillary nerve be a problem?
Is tying the knot in a transosseous technique equivalent to the anchor approach?
What are the pitfalls with osteoporotic bones? Is there a way to overcome the problem?
Augmentation, as a remedy for suture slippage?
Identification of portals
Webinar: “Transosseous opportunity, a practical overview”
Together with Prof. Alessandro Castagna, Dr. Pol Hujisman and Dr. Claudio Chillemi we will talk about transosseous surgery in the rotator cuff on April 28th at 7 pm.
Based on their experience, we will give a complete overview of the different transosseous procedures with the aim of explaining the different techniques and their advantages by comparing our understanding with the professionals of the sector.
The meeting will be an opportunity to give a clear and comprehensive idea of the possibilities and advantages that this approach can bring, to both the medical and patient perspective.
After being NCS Company Chief Operating Officier through the past four months, Yvonne Bokelman has been appointed new CEO of Alyve Medical.
